News

Voir

Rheumatoid arthritis: an anti-TNF-alpha drug is shown to improve gut dysbiosis

The administration of etanercept, an anti-TNF-alpha drug, induces partial restoration of the gut microbiota in patients with dysbiosis caused by rheumatoid arthritis.   What is the impact of rheumatoid arthritis (RA) and its treatment on the gut microbiota, and viveversa? To answer this q...
Voir

The intestinal microbiota, a predictor of response to anti-TNF alpha therapy?

Characterization of the intestinal microbiota could allow the efficacy of treatment with TNFa inhibitors to be predicted in patients suffering from ankylosing spondylitis. The presence of bacteria of the Burkholderiales order is thought to be synonymous with a better response to treatment, according...
  1. 1

Pages

Publications

Medias